Decreased incidence of graft-versus-host disease in bone marrow transplantation recipients treated with a combination of cyclosporine and methotrexate

MeSH terms

• Cyclosporins / administration & dosage
• Cyclosporins / therapeutic use*
• Drug Therapy, Combination
• Graft Survival
• Graft vs Host Disease / epidemiology
• Graft vs Host Disease / prevention & control*
• Histocompatibility
• Humans
• Methotrexate / administration & dosage
• Methotrexate / therapeutic use*
• Preoperative Care
• Sweden